FAQ: Everything you need to know about the $7M $SPPI $ASRT Settlement Payout
Q: What happened?
A: Spectrum Pharmaceuticals was accused of misleading investors about poziotinib’s dosing, its interactions with the FDA, and the status of the PINNACLE confirmatory study. After FDA briefing materials revealed concerns about the drug’s safety, efficacy, and dosing, $SPPI fell sharply, including a drop of more than 37% on September 20, 2022.
Q: Am I actually eligible?
A: If you bought $SPPI shares in 2022, you’re likely eligible. You don’t need to hold the stock still to claim; past losses count
Q: When is the deadline to submit a claim?
A: The current claim deadline is October 12, 2026.
Q: When do payouts happen?
A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
Check if you're eligible and file a claim: https://11th.com/cases/sppi-investor-settlement
The $15.95M Spectrum Pharmaceuticals investor settlement is now reviewing late claims.
Investors who purchased $SPPI / $ASRT shares between 2018 and 2021 may still be eligible to participate, late claims are currently being accepted: https://11th.com/cases/spectrum-investor-settlement
Shareholders who bought $SPPI $ASRT in 2022 have until October 12, 2026 to file a claim in the $7M Spectrum Pharmaceuticals settlement.
The settlement claims that Spectrum misled investors about poziotinib's dosing strategy, its communications with the FDA, and the status of its confirmatory PINNACLE study.
Eligible investors can still submit a claim before the deadline: https://11th.com/cases/sppi-investor-settlement
Everything You Need to Know About the $15.95M $SPPI / $ASRT Settlement Payout:
Q: What happened?
A: Spectrum Pharmaceuticals ($SPPI) agreed to a $15.95 million settlement over claims that it misled investors about the effectiveness and FDA approval prospects of its lead drug candidates, Poziotinib and Rolontis. Investors alleged the company concealed poor clinical results, manufacturing issues, and regulatory risks while continuing to present the drugs as being close to approval.
Q: Am I actually eligible?
A: If you bought $SPPI shares between 2018 and 2021, you’re likely eligible. You don’t need to still hold the stock to claim; past losses count
Q: When do payouts happen?
A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
Q: I missed the deadline. Is it too late?
A: You may still be able to file a late claim but acceptance depends on final approval by the court.
Check if you eligible and file your claim: https://11th.com/cases/spectrum-investor-settlement
The $7M Spectrum Pharmaceuticals investor settlement is now accepting claims.
Investors who purchased $SPPI /$ASRT shares in 2022 may still be eligible to participate: https://11th.com/cases/sppi-investor-settlement
$SPPI / $ASRT Settlement Update: The court has approved the $7M investor settlement.
The case alleged that Spectrum Pharmaceuticals misled the market about poziotinib’s dosing, FDA interactions, and the status of its PINNACLE confirmatory study. In September 2022, FDA briefing materials and an advisory committee meeting raised concerns about the drug’s safety, effectiveness, and approval path, causing $SPPI to fall sharply.
With the settlement now approved, eligible investors may be able to submit a claim: https://11th.com/cases/sppi-investor-settlement
$SPPI / $ASRT lost more than 88% after clinical trial failures and FDA setbacks, and the company later agreed to a $15.95M investor settlement.
If you bought or held $SPPI between 2018 and 2021, you may still be able to recover losses from, as late claims are currently being accepted: https://11th.com/cases/spectrum-investor-settlement
$SPPI Settlement Update: The court has approved the $7M investor settlement
The case alleged that Spectrum Pharmaceuticals misled the market about poziotinib’s dosing, its FDA interactions, and the status of the PINNACLE confirmatory study. After FDA briefing materials raised concerns in September 2022, $SPPI dropped 37%.
With the settlement now approved, eligible investors may be able to submit a claim: https://11th.com/cases/sppi-investor-settlement
Everything you need to know about the $15.95M $SPPI Settlement Payout
Q: What happened?
A: Spectrum Pharmaceuticals has agreed to settle with investors to resolve claims that it misled them about the effectiveness and FDA approval prospects of its two lead drug
Q: Am I actually eligible?
A: If you bought $SPPI shares between 2018 and 2021, you’re likely eligible. You don’t need to hold the stock still to claim; past losses count
Q: When do payouts happen?
A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
Q: I missed the deadline. Is it too late?
A: Not necessarily! We are currently processing 'Late-but-Valid' claims. The court often accepts these as long as the fund hasn't been distributed yet.
Q:Do I need to sell/lose my shares to get this settlement?
A: No, if you have purchased securities within the class period, you are eligible to participate.
You can check your eligibility and submit your claim: https://11th.com/cases/spectrum-investor-settlement
Update for $SPPI investors: the proposed $7M settlement has been submitted to the court for approval.
The settlement claims that Spectrum Pharmaceuticals misled investors about poziotinib's dosing, its communications with the FDA, and the status of the PINNACLE confirmatory study. After those issues came to light, the stock fell about 37%.
Investors who are eligible may now be able to submit a claim.
https://11th.com/cases/sppi-investor-settlement
@Luckybreak a majority of long term $SPPI / $ASRT holders will have been forced into selling this in the market prior to the result, otherwise like us now their cash will have been locked in this thing.
Nice to see $SPPI higher these days, but don't forget what happened back in the day.
$SPPI stock dropped nearly 80% after concerns emerged around the prospects of Poziotinib and Rolontis, ending up in a $15.95M investor settlement.
So if you missed the deadline, don’t miss this update. You may still be able to recover losses from $SPPI, as late claims are currently being accepted: https://11th.com/cases/spectrum-investor-settlement
Who can apply? If you bought or held $SPPI between March 7, 2018 and November 3, 2021, you're likely eligible even if you already sold your shares.
$SPPI Settlement update for Spectrum Pharmaceuticals investors.
The proposed $7M settlement has advanced to a Stipulation of Settlement, marking another step forward in the case. The settlement claims that Spectrum misled investors about poziotinib's dosing, its FDA interactions, and the status of the PINNACLE confirmatory study.
Investors who purchased shares between March 7, 2018 – August 5, 2021, you may be eligible to file your claim: https://11th.com/cases/sppi-investor-settlement
Don't forget that there is also another important settlement to watch for $SPPI
We have every detail, including how investors can get paid: https://11th.com/cases/sppi-investor-settlement
